Iguratimod prevents ovariectomy-induced bone loss and suppresses osteoclastogenesis via inhibition of peroxisome proliferator-activated receptor-γ

Iguratimod is known for its anti-inflammatory activities and therapeutic effects in patients with rheumatoid arthritis. It has previously been demonstrated that iguratimod attenuates bone destruction and osteoclast formation in the Walker 256 rat mammary gland carcinoma cell-induced bone cancer pain...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Ying-Xing, Sun, Yue, Ye, Ya-Ping, Zhang, Peng, Guo, Jia-Chao, Huang, Jun-Ming, Jing, Xing-Zhi, Xiang, Wei, Yu, Shi-Ying, Guo, Feng-Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779905/
https://www.ncbi.nlm.nih.gov/pubmed/28983607
http://dx.doi.org/10.3892/mmr.2017.7648

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5779905/
https://www.ncbi.nlm.nih.gov/pubmed/28983607
http://dx.doi.org/10.3892/mmr.2017.7648

Ejemplares similares